Literature DB >> 19949923

Flow cytometric evaluation of multidrug resistance proteins.

Adorjan Aszalos1, Barbara J Taylor.   

Abstract

There are several ways to detect proteins on cells. One quite frequently used method is flow cytometry. This method needs fluorescently labeled antibodies that can attach selectively to the protein to be investigated for flow cytometric detection. Flow cytometry scans individual cells, virtually without their surrounding liquid, and can scan many cells in a very short time. Because of this advantage of flow cytometry, it was adapted to investigate transport proteins on normal and cancerous human cells and cell lines. These transport proteins play important roles in human metabolism. Absorption in the intestine, excretion at the kidney, protection of the CNS compartment and the fetus from xenobiotics, and other vital functions depend on these transporters. However, several transporters are overexpressed in cancer cells. These overexpressed transporters pump out anticancer drugs from the cells and prevent their curative effects. The detection and quantitation of these types of transporters in cancer cells is important for this reason. Here, we review literature on flow cytometric detection of the three most studied transporters: P-glycoprotein, multidrug resistance-associated proteins, and breast cancer resistance protein.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19949923      PMCID: PMC7325859          DOI: 10.1007/978-1-60761-416-6_7

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  29 in total

1.  The "comparative growth assay": examining the interplay of anti-cancer agents with cells carrying single gene alterations.

Authors:  P Hausner; D J Venzon; L Grogan; I R Kirsch
Journal:  Neoplasia       Date:  1999-10       Impact factor: 5.715

2.  Theoretical and practical considerations for the measurement of P-glycoprotein function in acute myeloid leukemia.

Authors:  H J Broxterman; J Lankelma; H M Pinedo; C A Eekman; D C Währer; G J Ossenkoppele; G J Schuurhuis
Journal:  Leukemia       Date:  1997-07       Impact factor: 11.528

Review 3.  How to probe clinical tumour samples for P-glycoprotein and multidrug resistance-associated protein.

Authors:  H J Broxterman; J Lankelma; H M Pinedo
Journal:  Eur J Cancer       Date:  1996-06       Impact factor: 9.162

4.  Multidrug resistance protein 4 protects bone marrow, thymus, spleen, and intestine from nucleotide analogue-induced damage.

Authors:  Martin G Belinsky; Ping Guo; Kun Lee; Feng Zhou; Elena Kotova; Alex Grinberg; Heiner Westphal; Irina Shchaveleva; Andres Klein-Szanto; James M Gallo; Gary D Kruh
Journal:  Cancer Res       Date:  2007-01-01       Impact factor: 12.701

5.  Multidrug resistance proteins MRP3, MRP1, and MRP2 in lung cancer: correlation of protein levels with drug response and messenger RNA levels.

Authors:  L C Young; B G Campling; S P Cole; R G Deeley; J H Gerlach
Journal:  Clin Cancer Res       Date:  2001-06       Impact factor: 12.531

6.  Oleanolic acid inhibits the activity of the multidrug resistance protein ABCC1 (MRP1) but not of the ABCB1 (P-glycoprotein): possible use in cancer chemotherapy.

Authors:  F Braga; D Ayres-Saraiva; C R Gattass; M A M Capella
Journal:  Cancer Lett       Date:  2006-08-04       Impact factor: 8.679

7.  Expression and activity of multidrug resistance protein 1 in a murine thymoma cell line.

Authors:  Juliana Echevarria-Lima; Fernanda Kyle-Cezar; Daniela F P Leite; Luiz Capella; Márcia A M Capella; Vivian M Rumjanek
Journal:  Immunology       Date:  2005-04       Impact factor: 7.397

8.  Expression and functional analyses of breast cancer resistance protein in lung cancer.

Authors:  Shigeru Kawabata; Mikio Oka; Hiroshi Soda; Ken Shiozawa; Katsumi Nakatomi; Junji Tsurutani; Yoichi Nakamura; Seiji Doi; Takeshi Kitazaki; Kazuyuki Sugahara; Yasuaki Yamada; Shimeru Kamihira; Shigeru Kohno
Journal:  Clin Cancer Res       Date:  2003-08-01       Impact factor: 12.531

9.  Inhibition of P-glycoprotein and multidrug resistance-associated proteins modulates the intracellular concentration of lopinavir in cultured CD4 T cells and primary human lymphocytes.

Authors:  Omar Janneh; Elizabeth Jones; Becky Chandler; Andrew Owen; Saye H Khoo
Journal:  J Antimicrob Chemother       Date:  2007-09-21       Impact factor: 5.790

10.  Flow cytometric analysis of breast cancer resistance protein expression and function.

Authors:  Hans Minderman; Attaya Suvannasankha; Kieran L O'Loughlin; George L Scheffer; Rik J Scheper; Robert W Robey; Maria R Baer
Journal:  Cytometry       Date:  2002-06-01
View more
  1 in total

1.  PEGylated Liposomes Remotely Loaded with the Combination of Doxorubicin, Quinine, and Indocyanine Green Enable Successful Treatment of Multidrug-Resistant Tumors.

Authors:  Emma Grabarnick Portnoy; Alexander V Andriyanov; Hadas Han; Sara Eyal; Yechezkel Barenholz
Journal:  Pharmaceutics       Date:  2021-12-17       Impact factor: 6.321

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.